^
Association details:
Biomarker:XPA expression
Cancer:Germ Cell Tumors
Drug:cisplatin (DNA synthesis inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
New
Source:
Title:

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours

Excerpt:
...GCT patients with low XPA expression had significantly better overall survival than patients with high expression (hazard ratio = 0.38, 95% confidence interval: 0.12-1.23, p = 0.0228)...a correlation between inadequate or aberrant CDDP response and XPA expression found in GCT patients was also seen in GCT cell lines...
Secondary therapy:
Chemotherapy
DOI:
10.1186/s12885-019-6496-1